dievini Hopp Biotech Holding

dievini Hopp Biotech Holding is a German company that focuses on life and health sciences companies. Founded 2005 in Walldorf, Baden-Wurttemberg, Germany by Christof Hettich and Friedrich Bohlen, this private equity firm invests in late stage ventures. It usually invests in Series E, private equity rounds, Series F, and Series D rounds. Its portfolio companies include NovaliqNovaliq, immatics biotechnologies, Molecular Health, CureVac, and AC Immune. The company focuses on innovative therapeutics and diagnostics on life-threatening diseases, such as in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. Dievini’s activities are geographically centered in Germany and Europe.

dievini Hopp Biotech Holding is a German company that focuses on life and health sciences companies. Founded 2005 in Walldorf, Baden-Wurttemberg, Germany by Christof Hettich and Friedrich Bohlen, this private equity firm invests in late stage ventures. It usually invests in Series E, private equity rounds, Series F, and Series D rounds. Its portfolio companies include Novaliq, immatics biotechnologies, Molecular Health, CureVac, and AC ImmuneAC Immune. The company focuses on innovative therapeutics and diagnostics on life-threatening diseases, such as in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. Dievini’s activities are geographically centered in Germany and Europe.

dievini Hopp Biotech Holding is a German company that focuses on life and health sciences companies. Founded 2005 in WalldorfWalldorf, Baden-Wurttemberg, Germany by Christof Hettich and Friedrich Bohlen, this private equity firm invests in late stage ventures. It usually invests in Series E, private equity rounds, Series F, and Series D rounds. Its portfolio companies include Novaliq, immatics biotechnologies, Molecular Health, CureVac, and AC Immune. The company focuses on innovative therapeutics and diagnostics on life-threatening diseases, such as in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. Dievini’s activities are geographically centered in Germany and Europe.

dievini Hopp Biotech Holding is a German company that focuses on life and health sciences companies. Founded 2005 in Walldorf, Baden-Wurttemberg, Germany by Christof Hettich and Friedrich Bohlen, this private equity firm invests in late stage ventures. It usually invests in Series E, private equity rounds, Series F, and Series D rounds. Its portfolio companies include Novaliq, immatics biotechnologies, Molecular Health, CureVacCureVac, and AC Immune. The company focuses on innovative therapeutics and diagnostics on life-threatening diseases, such as in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. Dievini’s activities are geographically centered in Germany and Europe.